Insulin and glucagon action in the liver
Treatments studied
Part of Hormones & metabolism clinical trials.
This study looks at how the liver handles insulin and glucagon, two hormones that control blood sugar. It is for healthy adults to help researchers understand normal liver function.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 18 and 45 years old
- Your BMI is under 27 (a measure of body fat based on height and weight)
- Your blood sugar is normal (fasting glucose ≤ 95 mg/dL or HbA1c ≤ 5.8%)
- You have no personal or family history of diabetes
- You are not taking medications that affect blood sugar or digestion (like steroids, antidepressants, or narcotics)
- You have no active medical conditions like infections, heart, kidney, liver, or pancreas problems
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at how people with fatty liver and type 2 diabetes respond to glucagon, a hormone that helps control blood sugar. It may help researchers understand a condition called 'glucagon resistance' and find better treatments.
This study looks at how glucagon affects insulin release and blood sugar in people who do not have type 2 diabetes. It may help us understand normal glucose control better.
This trial tests how the hormone glucagon affects kidney function in healthy men. It may help researchers understand how glucagon works in the body.
This Phase 2 study tests how glucagon affects sugar and fat handling in the liver after a short period of calorie restriction. It may help researchers understand metabolic changes in people with type 2 diabetes and guide future treatments.
This study tests whether very low-carbohydrate diets change glucagon response in adults with type 1 diabetes. It may help researchers understand how diet affects blood-sugar control in people using insulin pumps and continuous glucose monitors.
This study looks at how the body makes glucagon (a hormone that raises blood sugar) in children and teens with new type 1 diabetes. It aims to understand why some people may have dangerous low blood sugars, so doctors can better prevent them in the future.
Hear when a new Diabetes (DM) trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.